Healthcare provider profile · identity verified

Augusto E. Hoyle, M.D.,

Family Practice · BOYNTON BEACH, FL · NPI 1477589919

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	361	50
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	329	39
Levothyroxine Sodium	Levothyroxine Sodium	233	66
Rosuvastatin Calcium	Rosuvastatin Calcium	211	71
Amlodipine Besylate	Amlodipine Besylate	187	64
Gabapentin	Gabapentin	170	45
Zolpidem Tartrate	Zolpidem Tartrate	168	27
Metformin Hcl	Metformin Hcl	162	55
Losartan Potassium	Losartan Potassium	157	54
Lisinopril	Lisinopril	149	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	134	21
Oxycodone Hcl	Oxycodone Hcl	130	12
Famotidine	Famotidine	127	44
Atorvastatin Calcium	Atorvastatin Calcium	122	42
Metoprolol Succinate	Metoprolol Succinate	120	42
Omeprazole	Omeprazole	119	45
Pantoprazole Sodium	Pantoprazole Sodium	111	35
Clonazepam	Clonazepam	107	13
Tamsulosin Hcl	Tamsulosin Hcl	103	35
Albuterol Sulfate Hfa	Albuterol Sulfate	102	30
Simvastatin	Simvastatin	98	26
Allopurinol	Allopurinol	94	30
Trazodone Hcl	Trazodone Hcl	92	25
Azithromycin	Azithromycin	86	60
Eliquis	Apixaban	82	12
Tramadol Hcl	Tramadol Hcl	80	20
Cephalexin	Cephalexin	78	45
Meloxicam	Meloxicam	74	33
Glimepiride	Glimepiride	72	23
Fluticasone Propionate	Fluticasone Propionate	70	34
Sucralfate	Sucralfate	70	22
Methocarbamol	Methocarbamol	69	28
Hydrochlorothiazide	Hydrochlorothiazide	68	25
Pravastatin Sodium	Pravastatin Sodium	67	26
Ketoconazole	Ketoconazole	64	24
Quetiapine Fumarate	Quetiapine Fumarate	63	11
Triamcinolone Acetonide	Triamcinolone Acetonide	63	28
Citalopram Hbr	Citalopram Hydrobromide	62	19
Ezetimibe	Ezetimibe	62	25
Carvedilol	Carvedilol	61	21
Metoprolol Tartrate	Metoprolol Tartrate	61	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	23
Temazepam	Temazepam	59	suppressed
Atenolol	Atenolol	54	19
Lorazepam	Lorazepam	53	suppressed
Alendronate Sodium	Alendronate Sodium	51	24
Levofloxacin	Levofloxacin	49	39
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	47	26
Duloxetine Hcl	Duloxetine Hcl	47	13
Fenofibrate	Fenofibrate Nanocrystallized	47	13
Memantine Hcl	Memantine Hcl	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	41	13
Diclofenac Sodium	Diclofenac Sodium	40	24
Buspirone Hcl	Buspirone Hcl	39	13
Clopidogrel	Clopidogrel Bisulfate	39	11
Escitalopram Oxalate	Escitalopram Oxalate	39	14
Furosemide	Furosemide	39	15
Linzess	Linaclotide	39	12
Valsartan	Valsartan	39	15
Cefuroxime	Cefuroxime Axetil	38	32
Doxycycline Hyclate	Doxycycline Hyclate	38	28
Mupirocin	Mupirocin	38	22
Ozempic	Semaglutide	38	suppressed
Celecoxib	Celecoxib	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	13
Prednisone	Prednisone	36	27
Morphine Sulfate Er	Morphine Sulfate	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	12
Pioglitazone Hcl	Pioglitazone Hcl	33	13
Ibuprofen	Ibuprofen	32	11
Januvia	Sitagliptin Phosphate	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	25
Diazepam	Diazepam	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	13
Oxybutynin Chloride	Oxybutynin Chloride	31	11
Topiramate	Topiramate	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Fentanyl	Fentanyl	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	13
Finasteride	Finasteride	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Lactulose	Lactulose	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Glipizide	Glipizide	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Testosterone	Testosterone	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Ofloxacin	Ofloxacin	16	14
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Risperidone	Risperidone	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Briviact	Brivaracetam	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Colchicine	Colchicine	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Belsomra	Suvorexant	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error